NASDAQ · CDIOW
Healthcare · Biotechnology
$0.01
Up+$0.00 (+2.97%)
Updated Sep 20, 2026, 12:51 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 13 trading sessions · Daily adjusted prices
CDIOW closed at $0.01 after 13 trading sessions, down 18.11% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $0.0104 | $0.0104 | $0.0104 | $0.0104 | 5.62K |
| Sep 17, 2026 | $0.0102 | $0.012 | $0.0101 | $0.0101 | 21.68K |
| Sep 16, 2026 | $0.0102 | $0.0123 | $0.0102 | $0.0103 | 1.89K |
| Sep 15, 2026 | $0.0133 | $0.0146 | $0.012 | $0.012 | 4.19K |
| Sep 11, 2026 | $0.0101 | $0.0101 | $0.01 | $0.01 | 9.78K |
| Sep 4, 2026 | $0.0124 | $0.016 | $0.0121 | $0.0159 | 18.13K |
| Sep 1, 2026 | $0.0144 | $0.0162 | $0.0144 | $0.0162 | 1.2K |
| Aug 31, 2026 | $0.0125 | $0.0169 | $0.0121 | $0.0167 | 27.29K |
| Aug 28, 2026 | $0.0167 | $0.0177 | $0.0167 | $0.0177 | 20.2K |
| Aug 27, 2026 | $0.0173 | $0.0174 | $0.013 | $0.0168 | 35.66K |
| Aug 26, 2026 | $0.0136 | $0.0177 | $0.0118 | $0.0175 | 7.7K |
| Aug 25, 2026 | $0.0138 | $0.0138 | $0.0138 | $0.0138 | 100 |
| Aug 24, 2026 | $0.0115 | $0.0142 | $0.0115 | $0.0127 | 3.67K |
The latest Smart Investors Daily articles mentioning CDIOW.
CDIOW research
Company profile and research snapshot.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Aug 26, 2026
CHICAGO, August 26, 2026--Cardio Diagnostics has released a new edition of the company’s rural health report: The State of Rural Hospitals and Cardiovascular Care.
SeekingAlpha · Aug 20, 2026
Cardio Diagnostics Holdings, Inc. (CDIO) Discusses Precision Molecular Advances and AI for Cardiovascular Disease Detection and Strategic Growth Initiatives...
Yahoo · Aug 18, 2026
CHICAGO, August 18, 2026--Cardio Diagnostics launched its in-house, high-complexity CLIA-certified laboratory in Iowa City, Iowa.
Yahoo · Jun 29, 2026
LOS ANGELES, CA - June 29, 2026 (NEWMEDIAWIRE) - Coronary heart disease ("CHD") remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume....
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CDIOW.
No results
No recent SID articles mention CDIOW.
